C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy
Lowe, G.; Rumley, A.; Woodward, M.; Vessey, M.
Thrombosis and Haemostasis 84(4): 730-731
2000
ISSN/ISBN: 0340-6245 PMID: 11057882 Document Number: 516651
Document emailed within 1 workday
Related Documents
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967De Maat, M.P.M.; Madsen, J.S.; Langdahl, B.; Bladbjerg, E.M.; Tofteng, C.L.; Abrahamsen, B.; Rejnmark, L.; Brixen, K.; Christensen, K.; Jespersen, J.ør.; Kristensen, S.ør.R. 2007: Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy Thrombosis and Haemostasis 97(2): 234-239
Lacut, K.; Oger, E. 2005: Hormone therapy and risk for venous thromboembolism in postmenopausal women La Revue du Praticien 55(4): 389-392
Genazzani, A.; Gambacciani, M.; Simoncini, T.; Anniverno, R.; Becorpi, A.M.; Biglia, N.; Brandi, M.L.; Guaschino, S.; Lello, S.; Massobrio, M.; Melis, G.B.; Mencacci, C.; Modena, M.G.; Nappi, C.; Nappi, R.E.; Pecorelli, S.; Petraglia, F.; Rosano, G.M.; Serra, G.B.; Sismondi, P.; Taddei, S.; Tonelli, F. 2007: Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 23(8): 436-444
Yonei, Y.; Takahashi, Y.; Hibino, S. 2007: Hormone replacement Up-to-date. Hormone replacement therapy in anti-aging medicine Clinical Calcium 17(9): 1400-1406
Collet, P. 2002: Hormone replacement therapy for menopause: continue or stop the prescription after 10 years? Should hormone replacement therapy be continued after 10 years? of course not! Gynecologie Obstetrique and Fertilite 30(9): 736-739
Farraj, R.S. 2004: Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Medical Journal 25(7): 848-851
Wang, H.S.; Wang, T.H.; Soong, Y.K. 2000: Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy Human Reproduction 15(1): 50-54
Szmit-Domagalska, J.; Petriczko, E.żb.; Drozdzynska, M.; Adler, G.; Horodnicka-Jozwa, A.; Ciechanowicz, A.; Walczak, M.ła. 2016: The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland Neuro Endocrinology Letters 37(4): 282-288
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Kakkar, V.V.; Bentley, P.G.; Lawrence, D.; de Haas, H.A.; Ward, V.P. 1979: Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement Münchener Medizinische Wochenschrift 121(36): 1152-1154
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Ohta, H. 2007: Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women Clinical Calcium 17(9): 1315-1324
Odlind, V.; Milsom, I.; Persson, I.; Victor, A. 2002: Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica 81(6): 482-490
Akishita, M. 2007: Hormone replacement Up-to-date. Effects of androgen replacement therapy on vascular function and atherosclerosis Clinical Calcium 17(9): 1385-1391
Heinemann, L.A.J.; Kluft, C.; Spannagl, M.; de Maat, M.P.M. 2002: The association between extrinsic activated protein C resistance and venous thromboembolism in women Contraception 66(5): 297-304
Jøssang, B.; Runde, I. 1992: Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(9): 1153-1155
Saitoh, H.; Matsumoto, H.; Yagyu, K.; Miyawaki, F.; Ide, H.; Furuse, A. 1988: Thromboembolism and antithrombogenic therapy after prosthetic valve replacement Kyobu Geka. Japanese Journal of Thoracic Surgery 41(2): 97-102